Is Kinesio Taping Effective to the Radial Nerve in Patients With Lateral Epicondylitis?
NCT ID: NCT03794219
Last Updated: 2019-09-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
80 participants
INTERVENTIONAL
2019-01-07
2019-08-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effectiveness of the Kinesiotaping in the Treatment of Chronic Lateral Epicondylitis
NCT06611709
Comparison of the Effects of Kinesio Tape and High-intensity Laser Therapy in Lateral Epicondylitis
NCT06382805
The Instant Effect of Kinesiology Taping in Patients With Knee OA
NCT05160246
Therapeutic Effects of Kinesiotape in the Management of Gonarthrosis
NCT07124169
Comparing the Effectiveness of Kinesio Taping and Knee Orthosis in Patients with Patellofemoral Pain Syndrome
NCT05995210
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Kinesio tape plus NSAID
Kinesio tape is applied 3 times a week for 2 weeks with a total of 6 sessions in addition to 750 mg/day oral naproxen.
Kinesio Tape
To all patients,750 mg/day oral naproxen is administered for 10 days. Additionally, in intervention group kinesio tape is applied 3 times a week for 2 weeks with a total of 6 sessions.
oral naproxen
750 mg/day oral naproxen is administered for 10 days.
NSAID
750 mg/day oral naproxen is administered for 10 days.
oral naproxen
750 mg/day oral naproxen is administered for 10 days.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Kinesio Tape
To all patients,750 mg/day oral naproxen is administered for 10 days. Additionally, in intervention group kinesio tape is applied 3 times a week for 2 weeks with a total of 6 sessions.
oral naproxen
750 mg/day oral naproxen is administered for 10 days.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* tenderness around the lateral humeral epicondyle following at least one of these provocation tests: resisted wrist extension, resisted middle finger extension or passive stretch of wrist extensors.
Exclusion Criteria
* presence of trigger point in the extensor muscles of the forearm
* history of proximal upper extremity or neck symptoms
* cervical pathology
* central or peripheral neurologic disease
* nerve entrapment syndromes
* surgical treatments for LE
* presence of condition that may prevent the patient using NSAIDs (i.e. gastrointestinal disorders, using anticoagulant)
* trauma history of upper extremity
* previous steroid injection around the lateral epicondyle
* physical therapy targeted for LE in the past 6 months
* presence of structures like fibrous bands, arc or recurrent radial artery around the radial nerve that may cause the entrapment of nerve
* pregnancy and having any systemic disease that may cause swelling at nerves such as diabetes mellitus, renal insufficiency, thyroid disease or rheumatic disease.
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ankara Education and Research Hospital
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Basak Mansiz-Kaplan
Principal Investigator of Department of Physical Medicine and Rehabilitation
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Basak Mansiz-Kaplan
Ankara, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
E10654
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.